Tuesday, November 17, 2026

Chugai/Omron/Omron Cynic-X begin demonstration experiment of laboratory automation system with high coexistence with humans.

Chugai, OMRON, and OMRON SCINIC-X have been engaged in joint research to realize a flexible laboratory automation system that is more flexible, versatile, and coexistent with people than existing systems in improving productivity in drug discovery research, improving the quality of experimental data, and automating research processes to realize new experimental activities. We have been engaged in joint research to realize a flexible laboratory automation system with greater flexibility, versatility, and coexistence with people than existing systems. The demonstration experiment will be conducted at Chugai's new research facility, Chugai Life Science Park Yokohama!

AI-based drug discovery and automation incorporating robotics technology

Chugai Pharmaceutical Co., Ltd. and OMRON Corporation (headquartered in Shimogyo-ku, Kyoto; Jyunta Tsujinaga, President and CEO; hereinafter "OMRON") and OMRON SCINIC-X Corporation (headquartered in Bunkyo-ku, Tokyo; Masaki Suwa, President and CEO; hereinafter "OSX") have been working together to improve productivity in drug discovery research and the quality of experimental data, (headquartered in Bunkyo-ku, Tokyo; Masaki Suwa, CEO; hereinafter "OSX") have been engaged in joint research to realize a flexible laboratory automation system that is more flexible, versatile, and coexistent with human beings than existing systems in the automation of research processes to improve productivity in drug discovery research, the quality of experimental data, and new experimental activities. The demonstration experiment will be conducted at Chugai's new research facility, Chugai Life Science Park Yokohama.

Based on the mutual sympathy for the future vision that both parties want to realize and on their mutual strengths, this joint research has been working to realize a flexible laboratory automation system that is highly coexistent with people so that researchers can conduct more creative experiments in drug discovery research. OMRON has been working to build an experiment automation system optimized for Chugai's drug discovery research by using its "Sensing & Control + Think" technology to realize the "automation that brings people to life," which is OMRON's goal for the wide variety of instruments and devices used in laboratories that have been difficult to handle with existing systems, The two companies have conducted joint research and development of a robot system that can automate experiments involving complex operations and continue drug discovery research in place of flexible and human-operated systems.

In this demonstration experiment, a robot system will be installed in Chugai Life Science Park Yokohama to establish and verify basic operations for drug discovery experiments, including transport of experimental samples and operation of equipment by a mobile robot, and operation of various experimental tools by a dual-armed robot. This lab automation system will enable drug discovery research experiments to continue even at night when no one is around, allowing people to spend more time on creative activities.

Through this demonstration experiment, Chugai will work on automation incorporating AI-based drug discovery and robotics technologies in a new research institute that will be responsible for drug discovery research, aiming to dramatically improve the productivity and quality of research. OMRON and OSX will apply the technologies realized through this joint research to accelerate the resolution of social issues through "human-intensive automation" in each of OMRON's focused domains.

Comments from the presidents of each company are as follows

Osamu Okuda, President and CEO, Chugai Pharmaceutical Co.

OMRON and OSX have been engaged in advanced joint research by combining their respective fields of expertise as partners aiming for next-generation laboratory automation utilizing robotics. The new system will further improve research productivity and efficiency by automating complex experiments that until now could only be performed by humans, and by allowing drug discovery research experiments to continue even when researchers are not available, such as during the night and on holidays. In addition, Chugai's next-generation laboratory automation aims to create an environment in which researchers can work in a highly productive manner. Chugai will steadily proceed with demonstration tests at the Chugai Life Science Park Yokohama, which will serve as a new drug discovery engine, and effectively utilize state-of-the-art robotic systems to create innovations, striving to "double R&D output" and "launch in-house global products every year" as stated in the growth strategy "TOP I 2030. We will continue to strive to double our R&D output and launch our own global products every year, as stated in our TOP I 2030 growth strategy.

Jyunta Tsujinaga, President and CEO, OMRON Corporation Comments

This joint research with Chugai is an extremely important and significant challenge for us to advance our core technology development and continue to create social needs, which is our corporate philosophy. The results of this research will bring important value to "extending healthy life expectancy" and "realizing a digital society," which are social issues that Chugai is addressing in its long-term vision SF2030. Together with Chugai, we will work to establish next-generation laboratory automation and bring new innovations to the field of drug discovery.

OSX President and CEO Masaki Suwa comments

Since its establishment in 2018, OSX has been designing the near future and backcasting from there to define research themes and engage in open innovation. This joint research was triggered by an inquiry from Chugai in response to a social communication*1 regarding research on robots that can be used universally in high-mix, low-volume production in the manufacturing industry, I am pleased to see that we have made significant progress toward social implementation. We will continue to take on the challenge of creating innovative technologies that evolve the relationship between humans and machines, with people at the center.
1:https://www.omron.com/jp/ja/news/2021/09/c0928.html(Won third place in the Product Assembly Challenge of the International Robot Competition at the World Robot Summit 2020 in Aichi, Japan, and received the "Japanese Society for Artificial Intelligence Award")

About Chugai Pharmaceutical

Chugai Pharmaceutical (Headquarters: Tokyo, Japan) is a research-based pharmaceutical company whose strengths lie in its unique drug discovery technology platform, including antibody engineering technology. As an important member of the Roche Group and a listed company on the prime market of the Tokyo Stock Exchange, Chugai is committed to the discovery of innovative drugs to meet unmet medical needs under independent management.

name of companyChugai Pharmaceutical Co.
EstablishmentMarch 8, 1943
LocationNihonbashi Mitsui Tower, 2-1-1 Nihonbashi Muromachi, Chuo-ku, Tokyo 103-8324, Japan
representativeOsamu Okuda
uniform resouce locatorhttps://www.chugai-pharm.co.jp/index.html

About Omron

OMRON Corporation is a leading automation company with its unique "Sensing & Control + Think" technology at its core, and is engaged in a wide range of businesses including control equipment, electronic components, social infrastructure, healthcare, and the environment.
Founded in 1933, OMRON now employs approximately 35,000 people worldwide and provides products and services in about 120 countries and regions. In the control equipment business, OMRON contributes to the creation of a prosperous society by providing automation technologies and product lines that revolutionize manufacturing and customer support.

name of companyOmron Corporation
EstablishmentMay 1933
LocationShiokoji-dori Horikawa-higashi-iru, Shimogyo-ku, Kyoto-shi, Kyoto
representativeJyunta Tsujinaga
uniform resouce locatorhttps://www.omron.com/jp/ja/

About Omron Scin-X

OMRON SCINIC-X Corporation is a strategic base for creating OMRON's vision of "near-future design. The company employs top researchers in a wide range of cutting-edge technologies, including AI, robotics, IoT, and sensing, to create "near-future designs" that integrate business models, technology strategies, and intellectual property strategies based on technological innovation and incorporate them into specific business architectures to solve social issues. We create "near-future designs" that integrate "business models," "technology strategies," and "intellectual property strategies" based on technological innovation and incorporate them into specific business architectures to solve social issues. We also accelerate the creation of "near-future designs" through joint research with universities and external research institutions.

name of companyOmron Cynic-X Corporation
EstablishmentFebruary 1, 2018
LocationNagase Hongo Building 3F, 5-24-5 Hongo, Bunkyo-ku, Tokyo
representativeMasaki Suwa, President and Representative Director
uniform resouce locatorhttps://www.omron.com/sinicx/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。